HSA

Hussman Strategic Advisors’s Corcept Therapeutics CORT Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.08M	Hold	42,000	–	–	0.7%	44
2025 Q1	$4.8M	Hold	42,000	–	–	1.16%	8
2024 Q4	$2.12M	Hold	42,000	–	–	0.63%	56
2024 Q3	$1.94M	Sell	42,000 -63,000	-60%	-$2.92M	0.48%	94
2024 Q2	$3.41M	Buy	105,000 +21,000	+25%	+$682K	0.94%	17
2024 Q1	$2.12M	Buy	84,000 +31,500	+60%	+$793K	0.49%	80
2023 Q4	$1.71M	Sell	52,500 -10,500	-17%	-$341K	0.39%	101
2023 Q3	$1.72M	Sell	63,000 -30,600	-33%	-$834K	0.33%	126
2023 Q2	$2.08M	Sell	93,600 -18,000	-16%	-$401K	0.38%	113
2023 Q1	$2.42M	Buy	111,600 +18,600	+20%	+$403K	0.38%	110
2022 Q4	$1.89M	Sell	93,000 -31,000	-25%	-$630K	0.31%	131
2022 Q3	$3.18M	Sell	124,000 -15,500	-11%	-$397K	0.55%	52
2022 Q2	$3.32M	Buy	139,500 +87,500	+168%	+$2.08M	0.57%	44
2022 Q1	$1.17M	Hold	52,000	–	–	0.23%	155
2021 Q4	$1.03M	Sell	52,000 -103,000	-66%	-$2.04M	0.23%	148
2021 Q3	$3.05M	Buy	155,000 +62,000	+67%	+$1.22M	0.67%	28
2021 Q2	$2.05M	Buy	93,000 +21,000	+29%	+$462K	0.42%	82
2021 Q1	$1.71M	Sell	72,000 -71,500	-50%	-$1.7M	0.35%	102
2020 Q4	$3.75M	Sell	143,500 -111,500	-44%	-$2.92M	0.98%	4
2020 Q3	$4.44M	Buy	255,000 +75,000	+42%	+$1.31M	1.17%	7
2020 Q2	$3.03M	Buy	180,000 +26,000	+17%	+$437K	0.77%	13
2020 Q1	$1.83M	Buy	154,000 +51,500	+50%	+$612K	0.49%	72
2019 Q4	$1.24M	Buy	102,500 +41,204	+67%	+$498K	0.39%	99
2019 Q3	$866K	Buy	+61,296	New	+$866K	0.25%	139
2018 Q3	–	Sell	-125,000	Closed	-$1.97M	–	226
2018 Q2	$1.97M	Buy	+125,000	New	+$1.97M	0.53%	86